Article
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.
Cancer cell - 16 Mar 2020
Zheng Ze-Yi, Anurag Meenakshi, Lei Jonathan T, Cao Jin, Singh Purba, Peng Jianheng, Kennedy Hilda, Nguyen Nhu-Chau, Chen Yue, Lavere Philip, Li Jing, Du Xin-Hui, Cakar Burcu, Song Wei, Kim Beom-Jun, Shi Jiejun, Seker Sinem, Chan Doug W, Zhao Guo-Qiang, Chen Xi, Banks Kimberly C, Lanman Richard B, Shafaee Maryam Nemati, Zhang Xiang H-F, Vasaikar Suhas, Zhang Bing, Hilsenbeck Susan G, Li Wei, Foulds Charles E, Ellis Matthew J, Chang Eric C
Abstract excerpt
We report that neurofibromin, a tumor suppressor and Ras-GAP (GTPase-activating protein), is also an estrogen receptor-α (ER) transcriptional co-repressor through leucine/isoleucine-rich motifs that are functionally independent of GAP activity. GAP activity, in turn, does not affect ER binding. Consequently, neurofibromin depletion causes estradiol hypersensitivity and tamoxifen agonism, explaining the poor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
